GAITHERSBURG, Md.–(BUSINESS WIRE) October 05, 2018 –Valneva USA, the U.S.
Read moreFDA Approves Accelerated 7-Day Vaccine Dosing Schedule for Ixiaro
Home » Medications »
FDA Approves Tegsedi
BOSTON and CARLSBAD, Calif., Oct. 05, 2018 (GLOBE NEWSWIRE) —
Read moreFDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 Years Old
October 5, 2018 — The U.S. Food and Drug Administration
Read moreOpioid overdoses, depression linked
The link between mental health disorders and substance abuse is
Read moreAronora’s New Blood Clot Treatment proCase Receives FDA Fast Track Designation
PORTLAND, Ore., Sept. 26, 2018 /PRNewswire/ — Aronora Inc., a
Read moreFDA Approves Nuzyra
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc.
Read moreER staffers under assault. Blame the opioid crisis.
(HealthDay)—Emergency departments are becoming increasingly violent places as doctors bear
Read moreLow self-esteem connected to greater risk for opioid use
Health, family and romance problems appear to be the particular
Read morePharmaceutical executive defends 400 percent price hike
(HealthDay)—A pharmaceutical executive is defending his company’s 400 percent price
Read moreAbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE:
Read more